LINC01267

Across TCGA pan-cancer cohorts, LINC01267 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of LINC01267’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC01267 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01267 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

LUAD, THCA, and COAD are the cancer types where LINC01267 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01267 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	All	−0.652	<.001	10	view →
THCA	Male	All	+0.291	<.001	10	view →
COAD	All	All	+0.103	.001	7	view →
LUSC	All	II,III,IV	−0.759	<.001	6	view →
BRCA	All	III,IV	−0.314	<.001	6	view →
UCEC	All	All	−1.016	.007	2	view →
READ	All	All	+0.236	.025	2	view →
KIRC	All	All	+0.057	.014	2	view →
KIRP	Male	II,III,IV	−0.045	.025	2	view →
LIHC	All	All	+0.034	.028	2	view →
KICH	Female	III,IV	+0.193	.009	1	view →
CHOL	All	All	+0.048	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

LINC01267–LUAD

Open the LUAD breakdown →